LIFEMD INC - LFMD 8 7/8 PERP (LFMDP) Stock Fundamental Analysis
USA - NASDAQ:LFMDP - US53216B2034
23.9 USD
-0.09 (-0.38%)
Taking everything into account, LFMDP scores 3 out of 10 in our fundamental rating. LFMDP was compared to 35 industry peers in the Health Care Technology industry. LFMDP has a bad profitability rating. Also its financial health evaluation is rather negative. LFMDP is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year LFMDP has reported negative net income.
LFMDP had a positive operating cash flow in the past year.
LFMDP had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LFMDP reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -12.28%, LFMDP is in line with its industry, outperforming 54.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 87.57%, LFMDP belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
LFMDP's Gross Margin has improved in the last couple of years.
LFMDP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
LFMDP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LFMDP has been increased compared to 1 year ago.
Compared to 5 years ago, LFMDP has more shares outstanding
LFMDP has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 7.04 indicates that LFMDP is not in any danger for bankruptcy at the moment.
LFMDP has a Altman-Z score of 7.04. This is amongst the best in the industry. LFMDP outperforms 85.71% of its industry peers.
LFMDP has a debt to FCF ratio of 2.31. This is a good value and a sign of high solvency as LFMDP would need 2.31 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.31, LFMDP is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Altman-Z | 7.04 |
ROIC/WACCN/A
WACC9.5%
2.3 Liquidity
A Current Ratio of 0.77 indicates that LFMDP may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.77, LFMDP is doing worse than 80.00% of the companies in the same industry.
LFMDP has a Quick Ratio of 0.77. This is a bad value and indicates that LFMDP is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.72, LFMDP is doing worse than 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
LFMDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.00%, which is quite impressive.
LFMDP shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.74%.
Measured over the past years, LFMDP shows a very strong growth in Revenue. The Revenue has been growing by 76.23% on average per year.
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
3.2 Future
The Earnings Per Share is expected to grow by 42.40% on average over the next years. This is a very strong growth
LFMDP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.29% yearly.
EPS Next Y86.4%
EPS Next 2Y57.71%
EPS Next 3Y42.4%
EPS Next 5YN/A
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
LFMDP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 90.82, the valuation of LFMDP can be described as expensive.
LFMDP's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of LFMDP to the average of the S&P500 Index (22.80), we can say LFMDP is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 90.82 |
4.2 Price Multiples
LFMDP's Enterprise Value to EBITDA is on the same level as the industry average.
LFMDP's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 160.66 | ||
| EV/EBITDA | 123.44 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as LFMDP's earnings are expected to grow with 42.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.71%
EPS Next 3Y42.4%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 9.28%, LFMDP is a good candidate for dividend investing.
LFMDP's Dividend Yield is rather good when compared to the industry average which is at 5.74. LFMDP pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, LFMDP pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.28% |
5.2 History
LFMDP has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
LFMDP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-34.38%
EPS Next 2Y57.71%
EPS Next 3Y42.4%
NASDAQ:LFMDP (9/24/2025, 8:15:27 PM)
23.9
-0.09 (-0.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners37.54%
Inst Owner ChangeN/A
Ins Owners17.39%
Ins Owner ChangeN/A
Market Cap1.08B
Analysts81.33
Price Target53.29 (122.97%)
Short Float %0%
Short Ratio0.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 9.28% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-34.38%
Div Incr Years0
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-258.37%
Min EPS beat(2)-635.29%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)-117.63%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-68.88%
EPS beat(12)5
Avg EPS beat(12)-64.04%
EPS beat(16)6
Avg EPS beat(16)-52.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)2.97%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.81%
Revenue beat(12)7
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.47%
PT rev (1m)90.05%
PT rev (3m)149.65%
EPS NQ rev (1m)-79.5%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-500%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 90.82 | ||
| P/S | 4.38 | ||
| P/FCF | 160.66 | ||
| P/OCF | 55.26 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 123.44 |
EPS(TTM)-0.21
EYN/A
EPS(NY)0.26
Fwd EY1.1%
FCF(TTM)0.15
FCFY0.62%
OCF(TTM)0.43
OCFY1.81%
SpS5.45
BVpS-0.04
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% | ||
| FCFM | 2.73% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Debt/EBITDA | 0.41 | ||
| Cap/Depr | 120.74% | ||
| Cap/Sales | 5.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 227.76% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 7.04 |
F-Score5
WACC9.5%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
EPS Next Y86.4%
EPS Next 2Y57.71%
EPS Next 3Y42.4%
EPS Next 5YN/A
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y89.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year279.84%
EBIT Next 3Y73.97%
EBIT Next 5YN/A
FCF growth 1Y162.68%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y816.14%
OCF growth 3YN/A
OCF growth 5Y133.93%